Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct-Dec;35(4):355-366.
doi: 10.5935/2965-2774.20230015-en.

Typical phenotypes of patients with acute respiratory failure with and without COVID-19 and their relationship with outcomes: a cohort study

[Article in English, Portuguese]
Mirella Cristine de Oliveira  1 , Rafaella Stradiotto Bernardelli  1 , Amanda Christina Kozesinski-Nakatani  1 , Joelle Turnes  1 , Fernanda Baeumle Reese  2 , Leandro Caramuru Pozzo  3 , Rafael Alexandre de Oliveira Deucher  4 , Caroline Uliana Rossi  5 , Luana Alves Tannous  6 , Álvaro Réa-Neto  1
Affiliations

Typical phenotypes of patients with acute respiratory failure with and without COVID-19 and their relationship with outcomes: a cohort study

[Article in English, Portuguese]
Mirella Cristine de Oliveira et al. Crit Care Sci. 2023 Oct-Dec.

Abstract

Objective: To compare, within a cohort of patients with acute respiratory failure, the phenotypes of patients with and without COVID-19 in the context of the pandemic and evaluate whether COVID-19 is an independent predictor of intensive care unit mortality.

Methods: This historical cohort study evaluated 1001 acute respiratory failure patients with suspected COVID-19 admitted to the intensive care unit of 8 hospitals. Patients were classified as COVID-19 cases and non-COVID-19 cases according to real-time polymerase chain reaction results. Data on clinical and demographic characteristics were collected on intensive care unit admission, as well as daily clinical and laboratory data and intensive care unit outcomes.

Results: Although the groups did not differ in terms of APACHE II or SOFA scores at admission, the COVID-19 group had more initial symptoms of fever, myalgia and diarrhea, had a longer duration of symptoms, and had a higher prevalence of obesity. They also had a lower PaO2/FiO2 ratio, lower platelet levels than non-COVID-19 patients, and more metabolic changes, such as higher levels of blood glucose, C-reactive protein, and lactic dehydrogenase. Patients with non-COVID-19 acute respiratory failure had a higher prevalence of chronic obstructive pulmonary disease/asthma and cardiopathy. Patients with COVID-19 stayed in the hospital longer and had more complications, such as acute kidney failure, severe acute respiratory distress syndrome and severe infection. The all-cause mortality rate was also higher in this group (43.7% in the COVID-19 group versus 27.4% in the non-COVID-19 group). The diagnosis of COVID-19 was a predictor of intensive care unit mortality (odds ratio, 2.77; 95%CI, 1.89 - 4.07; p < 0.001), regardless of age or Charlson Comorbidity Index score.

Conclusion: In a prospective cohort of patients admitted with acute respiratory failure, patients with COVID-19 had a clearly different phenotype and a higher mortality than non-COVID-19 patients. This may help to outline more accurate screening and appropriate and timely treatment for these patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of patients with severe acute respiratory syndrome with and without COVID-19 in terms of baseline characteristics and outcomes.
Figure 2
Figure 2
COVID-19 assessment as a predictor of intensive care unit mortality, regardless of age and Charlson Comorbidity Index score.
See this image and copyright information in PMC

References

    1. World Health Organization (WHO) WHO Coronavirus (COVID-19) Dashboard. 2021. Available from: https://covid19.who.int/
    1. Helmy YA, Fawzy M, Elaswad A, Sobieh A, Kenney SP, Shehata AA. The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. J Clin Med. 2020;9(4):1225. - PMC - PubMed
    1. Dennis JM, McGovern AP, Vollmer SJ, Mateen BA. Improving survival of critical care patients with coronavirus disease 2019 in England: a national cohort study, march to june 2020. Crit Care Med. 2021;49(2):209–214. - PMC - PubMed
    1. Bateson ML, McPeake JM. Critical care survival rates in COVID-19 patients improved as the first wave of the pandemic developed. Evid Based Nurs. 2022;25(1):13. - PubMed
    1. Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017–1032. - PMC - PubMed